Azacitidine As Post-Remission Therapy in Elderly

Azacitidine As Post-Remission Therapy in Elderly Patients
with Acute Myeloid Leukemia Significantly Prolongs
Disease-Free Survival: Interim Results from a Prospective,
Randomized, Open-Label, Phase III Multicenter Trial
by Esther Natalie Oliva, Caterina Alati, Prassede Salutari, Alessandra Freyrie, Anna
Candoni, Erica Simeone, Giovanna Ventura, Agostino Cortelezzi, Debora Capelli,
Pietro Leoni, Paolo Di Bartolomeo, Antonio Giovanni Marino, Patrizia Cufari,
Francesco Di Raimondo, Elisa Mauro, Antonio Volpe, Nicola Cascavilla, Pellegrino
Musto, Fortunato Morabito, Pasquale Niscola, Giorgina Specchia, and Francesca
Ronco
Blood
Volume 124(21):2299-2299
December 6, 2014
©2014 by American Society of Hematology
Esther Natalie Oliva et al. Blood 2014;124:2299
©2014 by American Society of Hematology
Esther Natalie Oliva et al. Blood 2014;124:2299
©2014 by American Society of Hematology
Esther Natalie Oliva et al. Blood 2014;124:2299
©2014 by American Society of Hematology